Identification of CTRC as A Potential Drug Target for Muscle-Related Conditions

Target Name: CTRC

NCBI ID: G11330

CTRC

Identification of CTRC as A Potential Drug Target for Muscle-Related Conditions

CTRC, or Chymotrypsin C, is a protein that is expressed in various tissues throughout the body, including muscle, heart, and brain. It is a member of the tyrosine kinase family and is involved in the regulation of cellular processes that are essential for muscle function, such as muscle growth, muscle contraction, and muscle relaxation.

Recent studies have identified CTRC as a potential drug target for a variety of muscle-related conditions, including muscle weakness, muscle disease, and muscle injuries. The protein is also a potential biomarker for muscle disease, which could be used to diagnose and monitor the progression of muscle-related conditions.

One of the reasons why CTRC has been identified as a potential drug target is its involvement in the regulation of muscle growth and development. CTRC has been shown to play a role in the growth of muscle fibers and in the development of muscle mass. Studies have shown that CTRC promotes muscle fiber growth and muscle mass in both young and older adults.

Another potential mechanism by which CTRC may be involved in muscle disease is its role in the regulation of muscle contractions. CTRC has been shown to play a role in the regulation of muscle contractions and has been linked to the development of muscle disease. For example, studies have shown that individuals with certain genetic mutations, which result in the loss of CTRC, may be at increased risk for the development of muscle disease.

In addition to its potential role in muscle growth and development, CTRC has also been identified as a potential biomarker for muscle disease. Studies have shown that CTRC levels are elevated in individuals with a variety of muscle-related conditions, including muscle weakness, muscle disease, and muscle injuries. This suggests that CTRC could be used as a diagnostic or monitoring tool for muscle disease.

While more research is needed to fully understand the role of CTRC in muscle disease, it is clear that it is an important protein that is involved in the regulation of muscle function. As such, CTRC is a potential drug target for a variety of muscle-related conditions and could be used as a biomarker for muscle disease.

Protein Name: Chymotrypsin C

Functions: Regulates activation and degradation of trypsinogens and procarboxypeptidases by targeting specific cleavage sites within their zymogen precursors. Has chymotrypsin-type protease activity and hypocalcemic activity

The "CTRC Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CTRC comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets